Gene-Modified, Disease-Resistant Pork Could Hit U.S. Shelves by 2025

In a major leap for agricultural biotechnology, gene-edited pork resistant to diseases like porcine reproductive and respiratory syndrome (PRRS) could be available for sale in the United States as early as 2025 according to BGR. This advancement builds on decades of genetic innovation since the introduction of the first genetically modified tomato 30 years ago.

A Breakthrough in Livestock Health

PRRS is one of the most devastating diseases affecting pigs, causing significant financial losses for farmers worldwide. The new gene-edited pigs, developed by international breeding company Genus, are engineered to resist this disease. By preventing PRRS, farmers can reduce herd mortality rates and decrease reliance on medical interventions, making livestock production more efficient and sustainable.

This isn’t the first attempt to create genetically modified super livestock. Previous breakthroughs include a “super stud” cow and earlier versions of gene-edited pigs. These new disease-resistant pigs represent a significant step forward, combining years of research with improved genetic editing technologies.

Potential Benefits and Concerns

The benefits of gene-edited pork extend beyond disease resistance. Healthier pigs mean reduced losses for farmers, potentially lower costs for consumers, and a more stable meat supply chain. However, critics caution against moving too quickly. There are concerns that farmers might overstock their livestock, exacerbating already contentious living conditions and potentially introducing new health risks.

The issue of overcrowded and unsanitary conditions in livestock farming has been a hot topic for decades, particularly in the U.S. Critics warn that improved disease resistance shouldn’t lead to complacency in addressing these ethical and environmental concerns.

Regulatory Hurdles and Global Approval

Even if the U.S. approves disease-resistant pork, it must also gain acceptance in key export markets to be commercially viable. Regulatory bodies in these regions will need to evaluate and approve the gene-edited product, a process that could take additional time.

This innovation is part of a broader wave of gene-editing research aimed at improving global food security. Other examples include ongoing trials to develop bananas resistant to Tropical Race 4 (TR4), a disease threatening global banana crops.

While gene-edited foods are nearing market readiness, their path to acceptance remains uncertain. If approved, disease-resistant pork could redefine the livestock industry and mark a significant milestone in the journey of genetically modified foods.

Photo: akophotography